Jolt #2: Healthcare Caffeine, WoundSource Edition
Part 1 in a series exploring the latest innovations in soft silicone wound care dressings
For decades now due to a patent, the only real option for soft silicone dressings existed with one company. Recently, that patent has expired. What does this mean for you? Simply put – new products and better values. Over the next few weeks, I will show you some of my favorite new soft silicone dressings and encourage you to evaluate and compare their features and performance to your current brand of choice.
The first stop on our journey is with New York based Advancis Medical, and their flagship brand of products – Eclypse.
Eclypse Super Absorbent Dressings by Advancis Medical
When you call Advancis Medical, the president of the company, David Bretan, picks up – usually on the first ring. I find this extremely refreshing in the world of automated extensions we now live in. Innovation is the driving force behind this company, and that paired with great customer service is the reason Advancis Medical is a company you should check out.
Eclypse is a line of super absorbent dressings featuring "diaper technology" that you may have seen before from brands such as Xtrasorb by Derma Sciences or Exu-Dry by Smith & Nephew. The key innovation to this product is that it is also available with a soft silicone contact layer. I can only think of one word to describe the silicone backing that Advancis Medical uses on their products – beautiful. The design is unlike anything I have ever seen before in a silicone contact layer. This is why Eclypse has made it to the top of my list as a product you should definitely add to your formulary.
A key feature of the Eclypse product line is the fact that they offer a sacral dressing as an option. Eclypse is the only super absorbent sacral dressing available on the market. This coupled with the fact that unique bordered and oval sizes are also available make this product the perfect selection for patients requiring pliable wound care dressings that easily conform to various contours of the body.
Reimbursement Advantages of Eclypse
Another driving force behind this product is the reimbursement advantages it offers to Medicare Part B Billers. I am always excited when you have a great product that offers superior performance for clinicians, and also is reimbursed well by Medicare for home care use. Here are two key reimbursement advantages Eclypse offers to providers:
Reimbursement Advantage #1: Unlike Xtrasorb or Exu-Dry, Eclypse is coded as an alginate/other gelling dressing under HCPCS A6196 and A6197. This offers higher reimbursement levels than most other specialty absorptive dressings on the market.
Reimbursement Advantage #2: Eclypse is also a great alternative to traditional foam dressings for patients with moderate to heavy exuding wounds. The maximum number of allowable dressing changes per month for Eclypse is 30, compared to only 12 for foam dressings – as daily dressing changes are allowed for this product by Medicare.
Case Studies, Product Literature and Samples
I wanted to provide you with all the information needed to evaluate Eclypse at your facility. Here are links to download case studies and product literature, and request samples for evaluation.
Eclypse Case Studies
I encourage you to take advantage of the free sample program. Get your hands on Eclypse and compare it to your current silicone dressing – I look forward to your feedback.
To learn more about this company and product visit http://www.woundsource.com/company/advancis-medical-usa-llc
About the Author
Colton Mason is the Senior Vice President of Sales & Marketing for Supreme Medical Fulfillment Systems - a national wholesale distributor of medical supplies and equipment that specializes in wound care.
His syndicated column, Healthcare Caffeine, is read by thousands of health care professionals every week – and he is pleased to deliver this special WoundSource Edition, featuring exclusive content specific to the wound care industry.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.